Relying on Guardant Reveal for continued health

https://www.youtube.com/watch?v=EIoBQl90Xcg

EDX Medical Group Plc (AQSE:EDX) is a global specialist in digital clinical diagnostics; developing and supporting high-performance products and services to provide cost-effective prediction of disease risk, inform clinical decision-making, enable personalised healthcare and accelerate the development of new medicines for cancer, neurology, heart disease and infectious diseases. EDX Medical entered into a strategic agreement with Guardant Health Inc., under which they distribute Guardant360® CDx and Guardant Reveal™.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
EDX Medical Group plc

More articles like this

EDX Medical Group plc

Genetic testing in cancer risk management

Discover how genetic testing can empower you to take control of your health by understanding your inherited cancer risks and taking proactive measures with NHS-supported tests.

EDX Medical Group plc

Innovative testing for testicular cancer detection

With the Movember campaign gaining momentum, it’s an opportune time to address testicular cancer, a condition that disproportionately affects young men. Each year in Europe, over 25,000 new cases are diagnosed, making it the most prevalent

EDX Medical Group plc

EDX Medical expands testicular cancer diagnostics

EDX Medical Group PLC, based in Cambridge, England, has announced a new step forward in the fight against testicular cancer by signing an exclusive agreement with mirdetect GmbH. This partnership allows EDX to distribute the innovative